Onconic Therapeutics Inc. (KOSDAQ:476060)
15,770
-80 (-0.50%)
Jun 10, 2026, 3:30 PM KST
181.61% (1Y)
| Market Cap | 716.08B +192.5% |
| Revenue (ttm) | 67.20B +196.2% |
| Net Income | 20.33B |
| EPS | n/a |
| Shares Out | 45.41M |
| PE Ratio | 35.23 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 177,510 |
| Open | 15,600 |
| Previous Close | 15,850 |
| Day's Range | 15,220 - 16,250 |
| 52-Week Range | 5,188 - 28,900 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Mar 20, 2026 |